Is U=U consistently known and implemented? A survey among different medical specialists in Brazil

Nenhuma Miniatura disponível
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Citação
INTERNATIONAL JOURNAL OF STD & AIDS, v.34, n.6, p.395-401, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Despite solid scientific evidence, the concepts of treatment as prevention (TASP) and Undetectable = Untransmittable (U = U) remain unfamiliar and underutilized for some healthcare providers. We conducted a self-completion survey to evaluate the knowledge of TASP/U = U in different medical specialties. Wilcoxon Rank-Sum, Chi-square and Fisher's exact tests were used for group comparisons and a logistic regression model was used to assess factors independently associated with U = U-non-supportive attitudes. 197 physicians were included; 74% agreed/strongly agreed that people living with HIV (PLHIV) under regular treatment with undetectable viral do not transmit HIV sexually. However, only 66% agree/strongly agree that PLHIV should be informed about that. The knowledge about these concepts was poorer among gynecologists, urologists and internal medicine specialists when compared to infectious diseases specialists after adjustment for age, race/skin color, gender, and sexual orientation. Our study found that knowledge of crucial concepts of HIV prevention may be lacking for some medical specialties. This highlights the need of improvement in medical education.
Palavras-chave
HIV (Human immunodeficiency virus), sexual behaviour, prevention, highly active antiretroviral therapy, medical education, medical specialty
Referências
  1. Bavinton BR, 2018, LANCET HIV, V5, pE438, DOI 10.1016/S2352-3018(18)30132-2
  2. Bavinton BR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-917
  3. Bor J, 2021, AIDS BEHAV, V25, P4209, DOI 10.1007/s10461-021-03296-8
  4. Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2022, B EP HIV AIDS
  5. Calabrese SK, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25559
  6. Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]
  7. Cooper V, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0778-6
  8. Copeland RM, 2017, AIDS CARE, V29, P1576, DOI 10.1080/09540121.2017.1317323
  9. Departamento de Vigil?ncia, 2019, PREV CONTR IST HIV H
  10. Global UNAIDS, 2021, HIV AIDS STAT FACT S, P2020
  11. Jamil MS, 2015, SEX TRANSM INFECT, V91, pA226, DOI 10.1136/sextrans-2015-052270.588
  12. Mehta SD, 2018, J SEX MED, V15, P1446, DOI 10.1016/j.jsxm.2018.08.007
  13. Murri R, 2003, AIDS CARE, V15, P581, DOI 10.1080/0954012031000134818
  14. Ngure K, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25466
  15. NIAID, 2018, US
  16. Okoli C, 2021, SEX TRANSM INFECT, V97, P18, DOI 10.1136/sextrans-2020-054551
  17. Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5
  18. Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0
  19. Rodger Alison J, 2016, JAMA, V316, P171, DOI 10.1001/jama.2016.5148
  20. Rueda S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011453
  21. Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355
  22. UNAIDS, 2018, US
  23. Zuniga JM., 2018, 3TH INT C HIV TREATM